🇺🇸 FDA
Patent

US 10723737

Compositions and methods for treating neurodegenerative diseases and cardiomyopathy

granted A61PA61P25/00A61P9/00

Quick answer

US patent 10723737 (Compositions and methods for treating neurodegenerative diseases and cardiomyopathy) held by The Regents of the University of California expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P25/00, A61P9/00